1. 1. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-48.
2. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-48.
3. Muñoz N, Bosch FX, De Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6): 518-527.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19.
5. Pim D, Thomas M, Banks L. The function of the human papillomavirus oncogenes. In: Viruses, Cell Transformation and Cancer Grand RJA (ed). Amsterdam: Elsevier; 2001. p. 145-192.
6. Hildesheim A. Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 1997; 89(11): 752-753.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010 Dec 15;127(12):2893-917.
8. Ferlay J ,Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013 Apr;49(6):1374-403.
9. WHO. Globocan 2012: estimated cancer incidence and mortality and prevalenc worldwide in 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
10. Health IMo. Iran Cancer Report 2009. Tehran:Cancer Registration Office;2012.
11. Centers for Disease Control and Prevention. Gynecologic Cancers: Cervical cancer risk factors. Page last updated: September 3, 2013. Available from: http://www.cdc.gov/cancer/cervical/basic_info/risk_factors.htm
12. Karimy M, Hasani M, Khorram R, et al. The effect of education based on of Health Belief Model on breast self-examination in the health volunteers in Zarandieh. Tabibe Shargh: J Zahedan Univ Med Sci 2008; 10(4):79- 87.
13. Nojomi M, Modares M, Erfani A, et al. The frequency of cervical cancer risk factors in women referred to hospitals in Tehran, 2005-2006. J Iran Univ Med Sci 2007; 14(56): 189-95.
14. Austin LT, Farah A, Mary-Jane M, et al. Breast and cervical cancer screening in Hispanic women: a literature review using the Health Belief Model. Women Health Issues 2002; 12(3): 208-216.
15. Wong LP, Wong YL, Low WY, et al. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J 2009; 50(1): 49-53.
16. Tabeshian A, Firoozeh F. The effect of health education on performing Pap smear test for prevention of cervix cancer in teachers of Isfahan City. J Azad Univ Med Sci North Branch 2009; 19(1): 43-8.
17. Society of Family Planning of Islamic Republic of Iran. Public education of fertility health. Tehran: Andishmand publ; 2001: 6-49.
18. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1-30.
19. Bzhalava D. Human papillomavirus reference clones. International Human Papillomavirus Reference Center. Available at: URL: http://www.hpvcenter.se/html/refclones.html, consulté en septembre; 2014.
20. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012; 30(Suppl 5):F55-70.
21. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/35–41.
22. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec 2014; 89(43):465-91.
23. Safaei A, Khanlari M, Momtahen M, Monabati A, Robati M, Amooei S, et al. Prevalence of high-risk human papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J Pathol Microbiol 2010; 53(4):681-5.
24. Shahramian I, Heidari Z, Mahmoudzadeh-Sagheb H, Moradi A, Forghani F. Prevalence of HPV infection and high risk HPV genotypes (16, 18), among monogamous and polygamous women, in Zabol, Iran. Iran J Public Health 2011; 40(3):113–21.
25. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100(Pt B):1-441.
2. Haghshenas M, Rafiei Alir, Zabihian F, Naghshvar F. Frequency of epstein barr virus in esophageal squamous cell carcinoma biopsies in mazandaran and golestan provinces in 2008. Iran J Microbiol 2009; 3(1): 43-8.
3. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
4. The function of the human papillomavirus oncogenes